136 related articles for article (PubMed ID: 7989524)
1. Factors affecting pregnancy success of human in-vitro fertilization in unstimulated cycles.
Paulson RJ; Sauer MV; Francis MM; Macaso T; Lobo RA
Hum Reprod; 1994 Aug; 9(8):1571-5. PubMed ID: 7989524
[TBL] [Abstract][Full Text] [Related]
2. The utility of a midcycle follicle-stimulating hormone boost in addition to human chorionic gonadotropin for timing of follicle aspiration in unstimulated in vitro fertilization cycles.
Lindheim SR; Sauer MV; Francis MM; Macaso T; Lobo R; Paulson RJ
Gynecol Obstet Invest; 1997; 43(2):76-8. PubMed ID: 9067710
[TBL] [Abstract][Full Text] [Related]
3. In vitro fertilization in unstimulated cycles: a clinical trial using hCG for timing of follicle aspiration.
Paulson RJ; Sauer MV; Francis MM; Macaso TM; Lobo RA
Obstet Gynecol; 1990 Nov; 76(5 Pt 1):788-91. PubMed ID: 2216225
[TBL] [Abstract][Full Text] [Related]
4. Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction.
Wikland M; Borg J; Hamberger L; Svalander P
Hum Reprod; 1994 Aug; 9(8):1430-6. PubMed ID: 7989500
[TBL] [Abstract][Full Text] [Related]
5. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
6. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
7. The significance of elevated early follicular-phase follicle stimulating hormone (FSH) levels: observations in unstimulated in vitro fertilization cycles.
Lindheim SR; Sauer MV; Francis MM; Macaso TM; Lobo RA; Paulson RJ
J Assist Reprod Genet; 1996 Jan; 13(1):49-52. PubMed ID: 8825167
[TBL] [Abstract][Full Text] [Related]
8. Follicular and estradiol parameters that improve success with natural cycle in vitro fertilization.
DiMattina M; Gordon JD; Botes A; Celia G; Payson M; Graves-Herring J
J Reprod Med; 2014; 59(5-6):267-73. PubMed ID: 24937968
[TBL] [Abstract][Full Text] [Related]
9. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
10. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
11. Possible factors affecting the development of oocytes in in-vitro maturation.
Mikkelsen AL; Smith S; Lindenberg S
Hum Reprod; 2000 Dec; 15 Suppl 5():11-7. PubMed ID: 11263532
[TBL] [Abstract][Full Text] [Related]
12. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
13. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.
Sharara FI; McClamrock HD
Hum Reprod; 1999 Nov; 14(11):2777-82. PubMed ID: 10548621
[TBL] [Abstract][Full Text] [Related]
14. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
Datta AK; Zosmer A; Tozer A; Sabatini L; Davis C; Al-Shawaf T
Reprod Biomed Online; 2012 May; 24(5):503-10. PubMed ID: 22417663
[TBL] [Abstract][Full Text] [Related]
15. The empty follicle syndrome: a pharmaceutical industry syndrome.
Zegers-Hochschild F; Fernández E; Mackenna A; Fabres C; Altieri E; Lopez T
Hum Reprod; 1995 Sep; 10(9):2262-5. PubMed ID: 8530648
[TBL] [Abstract][Full Text] [Related]
16. High Serum FSH is Associated with Brown Oocyte Formation and a Lower Pregnacy Rate in Human IVF Parctice.
Xu H; Deng K; Luo Q; Chen J; Zhang X; Wang X; Diao H; Zhang C
Cell Physiol Biochem; 2016; 39(2):677-84. PubMed ID: 27442586
[TBL] [Abstract][Full Text] [Related]
17. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
Claman P; Domingo M; Leader A
Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
[TBL] [Abstract][Full Text] [Related]
18. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels.
Martin JS; Nisker JA; Tummon IS; Daniel SA; Auckland JL; Feyles V
Fertil Steril; 1996 Jun; 65(6):1238-40. PubMed ID: 8641506
[TBL] [Abstract][Full Text] [Related]
19. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
[TBL] [Abstract][Full Text] [Related]
20. Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination.
Mercan R; Mayer JF; Walker D; Jones S; Oehninger S; Toner JP; Muasher SJ
Hum Reprod; 1997 Sep; 12(9):1886-9. PubMed ID: 9363700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
